Update in Hospital Medicine. Update in Hospital Medicine 2009
|
|
- Kelly Peters
- 5 years ago
- Views:
Transcription
1 2009 Bradley A. Sharpe, MD UCSF Division of Hospital Medicine PE in Acute COPD Exacerbations Question: What is the prevalence of PE in patients with COPD who need hospitalization? Design: Systematic review, prospective studies; COPD exacerbation + evaluated for PE; Conclusion:PE common in patients with COPD exacerbations; no clear predictors (maybe cancer? Low pco2?) Comment: Interpret with caution some flaws in data; But, should strongly consider PE in all pts with COPD exacerbation (esp. if no clear inciting factor) Think Could this be a PE? in COPD exac. Rizkallah, et al. Chest 2009;135;
2 Short Take: : Cancer in Unprovoked PE? In patients with new, unprovoked PE or DVT, what is the prevalence of cancer? In a systematic review including 3300 patients with unprovoked PE or DVT, the rate of new cancer diagnoses was 10% at 12 months. Approximately 6% were diagnosed at the time of the DVT/PE with history, exam, and basic labs. Carrier M, et al. Ann Intern Med. 2008;149:323. Duration antibiotics in COPD Exac. Question: In pts with COPD exacerbations, what is the appropriate duration of antibiotic therapy? Design: Meta-analysis of 21 RCTs, 10,700 pts with mild to moderate COPD Exacerbations; Conclusion: Extended course therapy does not improve clinical outcomes in mild to mod COPD exacerbations. Comments: Well done, data clear; Careful with sicker patients, respiratory failure where 7-10 days may be more appropriate Most COPD exac can be treated with 5 days El Moussaoui R, et al. Thorax. 2008;63:415.
3 Clopidogrel + PPI after ACS Question: After ACS, does combined use of clopidogrel + PPI increase adverse events? Design: Retrospective cohort study; large VA data; 8200 pts treated w/ clopidogrel after ACS; Conclusion: Clopidogrel + PPI after ACS assoc. increased risk of death and readmission for ACS; Risk increased approx 5% (20% 25%); Comments: PPI may inhibit plt effects of clopidogrel; But retrospective, unknown confounders? What to do? Use PPI only for clear indications (ulcer, etc.) Ho PH, et al. JAMA. 2009;301(9): Short Take: : Proton Pump Inhibitors There has been a documented association between PPIs and ventilator-associated (VAP) and community-acquired pneumonia (CAP). In a retrospective review of 64,000 admits (non- ICU), use of PPIs was associated with an increased risk of hospital-acquired pneumonia (HAP). The risk increase was ~ 1.0% (from 3.5% 4.5%). Herzig SJ, et al. JAMA. 2009;301:2120.
4 Short Take: : Proton Pump Inhibitors Could there be an association between PPIs and SBP (bacterial overgrowth translocation)? In a retrospective case-control study of patients with cirrhosis and ascites, PPI use was associated with an increased risk of SBP (odds ratio 4.3). Note, ~ 50% had no documented indication for the PPI. Bajaj JS, et al. Am J Gastro. 2009;104:1130. Summary Definitely 1) Treat mild-to-moderate COPD exacerbations for 5 days. Consider 1) Pulmonary embolism in all patients with a COPD exacerbation. 2) Cancer in up to 10% of all patients with unprovoked DVT or PE. 3) Carefully the indications for PPIs as they may increase risk of ACS with clopidogrel and risk of HAP and SBP.
5 Diagnostic Tests in Syncope Question: What are the best and most cost-effective tests in elderly patients w/ syncope? Design: Retrospective cohort study; pts > 65 yo. Noted diagnostic yield, cost per test; Conclusion: Orthostatic vitals was the best test; EKG, tele, and troponin I high-yield, low cost; Others should be based on history, exam, etc. Comments: Probably should not use shotgun approach ACC: echo, stress test, for unexplained syncope ACP guidelines: only hx, exam, EKG up front Reasonable to start w/ hx, exam, orthostatics, EKG, tele, troponin Mendu ML, et al. Arch Intern Med. 2009;169:1299. Reasons for Late Discharges What is different about patients discharged after 3pm? Prospective study of 209 general medical patients revealed 4 factors associated with later (and slower) discharges: 1) Use of ambulance at discharge 2) Discharge to a facility 3) Not filling prescription 4) Procedure or consult on the final day Chen LM, et al. JHM. 2009;4:226.
6 Medications in the Discharge Summary How well do we document discharge medications in the discharge summary? In a prospective evaluation of 577 discharge summaries, many had omitted meds, 32% of which could have led to harm. Approximately 17% of all medications had no obvious medical justification (PPIs). Perren A, et al. Qual Saf Health Care. 2009;18:205. Pending Tests in Discharge Summaries Do our current DC summaries adequately document pending tests? In a retrospective study of 696 discharge summaries at 2 academic centers, pending results of tests were mentioned only 16% of the time. Approximately 10% of these were actionable. Were MC, et al. JGIM. 2009;24:1003.
7 Re-engineering engineering the Discharge Can a focused re-engineered discharge process prevent readmissions? In an RCT of 750 patients, a multi-faceted discharge process (team, nurse, pharmacist) decreased readmissions and ED visits. Jack et al. Ann Intern Med 2009;24(3): Vancomycin Treatment Guidelines Question: What are best practices for the use and monitoring of vancomycin? Design: Expert panel w/ literature review; Guidelines for dosing & monitoring Conclusion: Measure trough after 4 th dose, goal > 10mg/dL; Goal 15-20mg/dL for invasive MRSA infections; No indication to measure peak values Comments: MRSA infections increasing; Some evidence but follow expert guidelines; Consult with local pharmacist if needed Rybak MJ, et al. CID. 2009;49:325.
8 Diagnosing Clostridium difficile Question: How can we most effectively diagnose C difficile colitis in hospitalized patients? Design: Narrative expert review (Annals); Retrospective cohort study; Conclusion: Only send if 3 loose stools in a day; Many possible testing options; Generally no indication to send stool twice; Comments: C difficile is common, accurate diagnosis is key Should not be kneejerk reaction to diarrhea Figure out which test you are using (all different) Peterson LR, et al. Ann Intern Med. 2009;151:176. Nemat H, et al. Am J Gastro. 2009;104:2035. Summary Definitely 1) Follow vancomycin treatment guidelines. 2) Dictate accurate discharge medications and pending tests. Consider 1) Limited initial evaluation for syncope (orthostatics, EKG, tele, troponin). 2) Sending C diff only if 3 loose stools. Stop 1) Sending stool for C diff multiple times.
9 Intensive Glucose in the ICU Question: In a mixed med-surg ICU, what are the risks/benefits of intensive glucose control? Design: RCT, 42 ICUs, 6104 patients; ICU > 3 days; Goal mg/dl vs. < 180 mg/dl Conclusions:Tight glucose control increased hypoglycemia and mortality; true in all subgroups of patients Comment: Very well done RCT Balance risks vs. risks of hyperglycemia? Maybe goal mg/dl??? NICE-SUGAR. NEJM. 2009;360:1283. Catheter-associated associated UTI Question: How well do we diagnose real UTIs in patients with foley catheters? Design: Retrospective analysis; 280 urine cultures; All pts w/ Foley or condom cath for >24 hrs Conclusions:Up to 1/3 of pts w/o infection were given abx; Older pts, gram neg rods, higher urine WBC predicted inappropriate abx Comment: Likely are over-treating patients; cost/resist. Pyuria + bacteria alone is not enough. Think is this an infection? before you treat. CopeM, et al. CID. 2009;48:1182.
10 End of Life Recommendations Question: Should physicians recommend limitations of life support to surrogates? Design: Prospective study, 169 surrogate decisionmakers for critically ill patients; Watched videos of simulated family meetings Conclusion: Up to 40% preferred no MD recommendation Felt might make the process harder Comment: No consensus on if we should provide recs Best practice probably to ask if surrogates want a recommendation White DB, et al. Am J Respir Crit Care Med. 2009;180:320. Interpreted Family Meetings How do interpreted family meetings differ from non-interpreted family meetings? Family members from 10 interpreted and 51 noninterpreted conferences were interviewed. Families received less information and less emotional support in interpreted conferences. Thornton JD, et al. Crit Care Med. 2009;37:89.
11 Summary Definitely 1) Stop treating patients who do not have true catheter-associated urinary tract infections. 2) Be aware of the emotional support and information you provide in interpreted family meetings. Consider 1) Making goal blood sugar in the ICU mg/dl. 2) Asking surrogates if they would like you to make a recommendation regarding limits in life support For the full powerpoint presentation: sharpeb@medicine.ucsf.edu
10/27/13. Update in Hospital Medicine Update in Hospital Medicine Update in Hospital Medicine 2013
2013 Brad Sharpe, MD, SFHM, FACP UCSF Division of Hospital Medicine Michelle Mourad, MD, SFHM, FACP UCSF Division of Hospital Medicine 2013 Updated literature March 2012 March 2013 Process: CME collaborative
More informationUpdate in Hospital Medicine
Update in Hospital Medicine 2017-2018 Brad Sharpe, MD SFHM UCSF Division of Hospital Medicine 2017-2018 Updated literature March 2017 March 2018 Process: CME collaborative review of journals Including
More informationVS. Present updated literature since April Process: CME collaborative review of journals. Four hospitalists ranked articles
Bradley A. Sharpe, MD Associate Professor of Clinical Medicine UCSF Division of Hospital Medicine sharpeb@medicine.ucsf.edu VS. Present updated literature since April 2009 Process: CME collaborative review
More informationVS. Chose articles based on 3 criteria: Present updated literature since April 2009
2010 VS. Bradley A. Sharpe, MD Associate Professor of Clinical Medicine UCSF Division of Hospital Medicine sharpeb@medicine.ucsf.edu 2010 Present updated literature since April 2009 Process: CME collaborative
More informationUpdate in Hospital Medicine Bradley A. Sharpe, MD Assistant Clinical Professor UCSF Division of Hospital Medicine
2008 Bradley A. Sharpe, MD Assistant Clinical Professor UCSF Division of Hospital Medicine VS. 2008 Updated literature in addition to other speakers Focus on breadth rather than depth Practical applications
More information11/3/11 VS. Updated literature since October Process: CME collaborative review of journals. Three hospitalists ranked articles
Michelle Mourad, MD Brad Sharpe, MD UCSF Division of Hospital Medicine VS. Updated literature since October 2010 Process: CME collaborative review of journals Including ACP J. Club, J. Watch, etc. Three
More informationPost-Resuscitation Care. Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena
Post-Resuscitation Care Prof. Wilhelm Behringer Center of Emergency Medicine University of Jena Conflict of interest Emcools Shareholder and founder, honoraria Zoll: honoraria Bard: honoraria, nephew works
More informationBradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF -- William Osler, M.D.
Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu a. An ailment that often leads to suffocation and death. b. A friend of the aged. c. A common
More information1/21/2016. Overview. Significance
Asymptomatic Bacteriuria: Myths, Magic and Management Christopher Ohl MD Professor of Medicine, Section on Infectious Diseases Wake Forest School of Medicine, Winston Salem, NC Slide credits to Katie Wallace,
More informationPneumonia Severity Scores:
Pneumonia Severity Scores: Are they Accurate Predictors of Mortality? JILL McEWEN, MD FRCPC Clinical Professor Department of Emergency Medicine University of British Columbia Vancouver, BC Canada President,
More informationWriting with purpose. Make IT real and simple. On the Medicine Wards for Medical Students, Interns, and Residents
Writing with purpose Make IT real and simple On the Medicine Wards 2017-2018 for Medical Students, Interns, and Residents Omar S. Darwish, MS, DO Health Science Assistant Professor Coordinator of the M&M
More informationAntibiotic Utilization in SNF/LTC Role of Consultant Pharmacist
Antibiotic Utilization in SNF/LTC Role of Consultant Pharmacist Hennie Garza, M.S.Pharm, R.Ph., C.D.E. Director of Pharmacy Senior Care Centers Dallas, TX Potential Roles for Consultant Pharmacists Provide/help
More informationThe following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS.
Page 1 The following content was supplied by the author as supporting material and has not been copy-edited or verified by JBJS. Appendix TABLE E-1 Care-Module Trigger Events That May Indicate an Adverse
More informationCAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as:
1. In 1898, William Osler described community-acquired pneumonia as: Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu I have no relevant financial
More informationDisclosure. Overview. Objectives. Five Noteworthy Outpatient Publications. Factors Affecting Antibiotic Prescribing 7/24/2013
47 th Annual Meeting August 2-4, 2013 Orlando, FL Five Noteworthy Outpatient Publications R. Vandervoort, Pharm.D. Disclosure I do not have a vested interest in or affiliation with any corporate organization
More informationOptimal Drugs for ICU Stress Ulcer Prophylaxis: Other. Grand Rounds Monday August 9, 2010 Teresa Jones R2
Optimal Drugs for ICU Stress Ulcer Prophylaxis: Other Grand Rounds Monday August 9, 2010 Teresa Jones R2 Outline Options besides PPIs Comparison to PPIs Negative Effects of PPIs Conclusion Do we really
More informationUpdate in Hospital Medicine 2013
2013 VS. Brad Sharpe, MD, SFHM, FACP UCSF Division of Hospital Medicine 2013 2013 Updated literature since March 2012 Process: CME collaborative review of journals Including ACP J. Club, J. Watch, etc.
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More informationUpdates to pharmacological management in the prevention of recurrent Clostridium difficile
Updates to pharmacological management in the prevention of recurrent Clostridium difficile Julia Shlensky, PharmD PGY2 Internal Medicine Resident September 12, 2017 2017 MFMER slide-1 Clinical Impact Increasing
More informationJourney to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer
Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical
More informationUpdate in Hospital Medicine
2017-2018 VS. Brad Sharpe, MD SFHM 2017-2018 2017-2018 Updated literature March 2017* March 2018 Process: CME collaborative review of journals Including ACP J. Club, J. Watch, etc. Independent analysis
More informationBradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF
Maximizing Care for Community- Acquired Pneumonia Bradley A. Sharpe, M.D. Associate Professor Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu 1. In 1898, William Osler described community-acquired
More informationUpdate in Hospital Medicine 2013
2013 Brad Sharpe, MD, SFHM, FACP UCSF Division of Hospital Medicine VS. 1 2013 Updated literature since March 2012 Process: CME collaborative review of journals Including ACP J. Club, J. Watch, etc. Five
More informationThink Globally: Strategies to Improve the Culture of Antibiotic Prescribing
Think Globally: Strategies to Improve the Culture of Antibiotic Prescribing October 11, 2017 Paul Lewis, PharmD, BCPS (AQ-ID) Johnson City Medical Center Johnson City, TN 1 Outline Introduction to stewardship
More informationPhysician's Core Measure Pocket Guide AMI
Physician's Core Measure Pocket Guide Core Measure Hotline: Ext. 4448 http://centegramedsource.com Indicator: AMI AMI VER. 9/2018 MUST document WHY no ASA unless there is documentation of contraindication
More informationPractical Guide to Safety of PPIs What to Tell Your Patient. Proton Pump Inhibitors
Practical Guide to Safety of PPIs What to Tell Your Patient Joel E Richter, MD, FACP, MACG Professor and Director Division of Digestive Diseases and Nutrition Joy Culverhouse Center for Esophageal Diseases
More informationLIFEGIFT BRAIN DEATH PLAN
Diagnosis Weight Allergies Admit/Discharge/Transfer ***THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING*** Patient Status Pt Status: Inpatient (Inpatient only procedure)
More informationYear in Review
2016-2017 VS. Brad Sharpe, MD SFHM Brad Monash, MD Division of Hospital Medicine 2016-2017 2016-2017 Updated literature September 2016 September 2017 Process: CME collaborative review of journals Including
More informationUpdate in Hospital Medicine 2010
2010 Bradley Sharpe, MD UCSF Division of Hospital Medicine Romsai Boonyasai, MD, MPH Johns Hopkins Department of Medicine Anneliese Schleyer, MD University of Washington Dept. of Medicine Sponsored by
More informationCurrent Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook
Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics Deborah Cook Objectives VAP The Old: Gastropulmonary route of infection The New: Microbiome modification Role of acid suppression Influence
More informationHow do we define pneumonia?
Robert L. Keith MD FCCP Associate Professor of Medicine Division of Pulmonary Sciences & Critical Care Medicine Denver VA Medical Center University of Colorado Denver How do we define pneumonia? Fever
More informationJeffrey Tabas, MD. sf g h. Risk Assessment Do we understand risk stratification? Are we limiting radiation /contrast with the PERC rule and D-Dimers?
Pulmonary Embolism Update Jeffrey Tabas, MD Professor UCSF School of Medicine Emergency Department San Francisco General Hospital Disclosure No Financial Relationships to Disclose No significant investments
More informationThe Potential For Microbiome Modification In Critical Illness. Deborah Cook
The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationCare Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience
More informationUpdate in Hospital Medicine. Disclosures 10/30/2017. none Oregon Chapter ACP Scientific Meeting
Update in Hospital Medicine 2017 Oregon Chapter ACP Scientific Meeting DATE: November 4, 2017 PRESENTED BY: Joel Papak, MD FACP Disclosures none 1 How well do you think you keep up with the medical literature?
More informationStress Ulcer Prophylaxis In The ICU. Scott W. Wolf Anesthesiology Critical Care Medicine
Stress Ulcer Prophylaxis In The ICU Scott W. Wolf Anesthesiology Critical Care Medicine Some history Stress Ulceration described in ICU patients as long as 45 years ago Patients had a constellation of
More informationUpdate in the Literature 2012
Update in the Literature 2012 Mel L. Anderson, MD, FACP Chief, Hospital Medicine Section Associate Chief, Medical Service Denver VA Medical Center Associate Professor of Medicine University of Colorado
More informationMichael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center
CA-MRSA Pneumonia Michael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center Professor of Clinical Medicine Weill Cornell
More informationDo PPIs Reduce Bleeding in ICU? Revisiting Stress Ulcer Prophylaxis. Deborah Cook
Do PPIs Reduce Bleeding in ICU? Revisiting Stress Ulcer Prophylaxis Deborah Cook ICU-Acquired Upper GI Bleeding Case series of 300 ICU patients describing stressrelated erosive syndrome Frequent Fatal
More informationLow Risk Chest Pain. Objectives. Disclosure. Case 1. Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine
Disclosure Low Risk Chest Pain No Financial Relationships to Disclose No significant investments or savings Unlimited Expenses Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School
More informationGuidelines 2017 for the management of hospitalacquired pneumonia (HAP) and. ventilator-associated. pneumonia (VAP)
Guidelines 2017 for the management of hospitalacquired pneumonia (HAP) and ventilator-associated Modifiez le style des sous-titres du masque pneumonia (VAP) Filip Moerman Présentation pour les soins int
More informationBrice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine
Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important
More informationIntroductions. Rational Use of Diagnostic Tests: From the Old Standards to the Latest in Genetic Testing. Goals of this Workshop 8/12/2010
Rational Use of Diagnostic Tests: From the Old Standards to the Latest in Genetic Testing Michael G. Shlipak, MD, MPH Professor of Medicine, UCSF Chief, Division of General Internal Medicine San Francisco
More informationClinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)
VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin
More informationIH Pharmacy Live Rounds
IH Pharmacy Live Rounds Effect of Vancomycin plus Rifampicin in the Treatment of Nosocomial Methicillin-resistant Staphylococcus aureus Pneumonia Sandra Katalinic, Pharmacy Resident Kelowna General Hospital
More informationPOCUS is the future of the physical exam
Diagnostic Point of Care Ultrasound For Hospitalists Nima Afshar MD Associate Professor Trevor Jensen MD MS Assistant Professor Department of Medicine, UCSF Oct 2018 POCUS is the future of the physical
More informationThe Urinary Tract Infection (UTI) Program for Long-Term Care
The Urinary Tract Infection (UTI) Program for Long-Term Care Jacquelyn Quirk, Evaluation Specialist, Public Health Ontario Eva Skiba, Regional IPAC Specialist, Public Health Ontario October 3, 2017 IPAC
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationAppropriate Use of Proton Pump Inhibitors (PPIs) Anderson Mabour, Pharm.D., BCPS Clinical Pharmacy Specialist
Appropriate Use of Proton Pump Inhibitors (PPIs) Anderson Mabour, Pharm.D., BCPS Clinical Pharmacy Specialist Disclosures I have no actual or potential conflicts of interest to report in relation to this
More informationManagement of Clostridium Difficile: Total Colectomy versus Colon Sparing Surgery
Management of Clostridium Difficile: Total Colectomy versus Colon Sparing Surgery Rahul Narang, MD Colon and Rectal Surgery Assistant Professor of Surgery No Disclosure Clostridium Difficile Colitis: Treatments,
More informationFamily Medicine Clinical Pharmacy Forum Vol. 4, Issue 5 (September/October 2008)
1 Family Medicine Clinical Pharmacy Forum Vol. 4, Issue 5 (September/October 2008) Family Medicine Clinical Pharmacy Forum is a brief bi-monthly publication from the Family Medicine clinical pharmacists
More informationLONG -TERM USE OF PPIS: INDICATIONS, BENEFITS AND HARMS. Jihane Naous, M.D.
LONG -TERM USE OF PPIS: INDICATIONS, BENEFITS AND HARMS Jihane Naous, M.D. Objectives Identify the conditions supported by AGA/ACG guidelines necessitating long-term use of daily PPIs, Recognize which
More informationLanny Hsieh, M.D. Infectious Diseases Hospitalist Program
Lanny Hsieh, M.D. Infectious Diseases Hospitalist Program Definition of Fever Arbitrary 38.0-38.4 (low grade may be significant in immunocompromised patients) > 38.5 (nurse will call you) Be aware of
More informationCARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: The target audience for this Care Guideline is all MultiCare providers and staff, including those associated with our clinically integrated
More informationUpdate in Hospital Medicine 2017
Update in Hospital Medicine 2017 Elizabeth Burton, MD, CCFP Hospitalist, QE II Health Science Centre, Halifax, NS September 30, 2017 15 th Annual Canadian Society of Hospital Medicine Faculty/Presenter
More informationCYP2C19-Proton Pump Inhibitors
CYP2C19-Proton Pump Inhibitors Cameron Thomas, Pharm.D. PGY2 Clinical Pharmacogenetics Resident St. Jude Children s Research Hospital February 1, 2018 Objectives: CYP2C19-PPI Implementation Review the
More informationAndrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015
The TIMES Project: (Time to Initiation of Antibiotic Therapy in Medical Patients Presenting to the Emergency Department with Sepsis) - Preliminary Findings Andrea Blotsky MDCM FRCPC General Internal Medicine,
More informationBest Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation
Best Practices in Acute Care Precepting at the Sharp Chula Vista Medical Center Medicine Rotation Pratima Patel, PharmD Clinical Pharmacist Medicine Rotation Preceptor Sharp Chula Vista Medical Center
More informationLung Day University of Washington. June 17, Translating Data Into Practice in the MICU. Richard K. Albert, M.D.
Lung Day 2011 University of Washington June 17, 2011 Translating Data Into Practice in the MICU Richard K. Albert, M.D. Chief of Medicine Denver Health Professor of Medicine University of Colorado Adjunct
More informationCLOSTRIDIUM DIFICILE. Negin N Blattman Infectious Diseases Phoenix VA Healthcare System
CLOSTRIDIUM DIFICILE Negin N Blattman Infectious Diseases Phoenix VA Healthcare System ANTIBIOTIC ASSOCIATED DIARRHEA 1978: C diff first identified 1989-1992: Four large outbreaks in the US caused by J
More informationStaging Sepsis for the Emergency Department: Physician
Staging Sepsis for the Emergency Department: Physician Sepsis Continuum 1 Sepsis Continuum SIRS = 2 or more clinical criteria, resulting in Systemic Inflammatory Response Syndrome Sepsis = SIRS + proven/suspected
More informationLong-Term Care Updates
Long-Term Care Updates April 2017 Bezlotoxumab to Prevent Recurrent Infection By Amy Wilson, PharmD and Zara Risoldi Cochrane, PharmD, MS, FASCP Introduction The Gram-positive bacteria is a common cause
More informationWhat is sepsis? RECOGNITION. Sepsis I Know It When I See It 9/21/2017
Sepsis I Know It When I See It September 15, 2017 Matthew Exline, MD MPH Medical Director, Medical ICU What is sepsis? I shall not today attempt further to define the kinds of material [b]ut I know it
More informationSCORES FOR 4 TH QUARTER, RD QUARTER, 2014
SCORES FOR 4 TH QUARTER, 2013 3 RD QUARTER, 2014 PATIENT SATISFACTION SCORES (HCAHPS): 4 STARS OUT OF 5 (ONLY 4 AREA ACUTE CARE HOSPITALS RECEIVED A 4-STAR RATING. NONE ACHIEVED 5-STARS). STRUCTURAL MEASURES:
More informationWhat s New for Clostridium difficile John Lynch MD MPH Harborview Medical Center University of Washington
What s New for Clostridium difficile 2013 John Lynch MD MPH Harborview Medical Center University of Washington Pathogenic Mechanisms of Diarrhea Toxins: Preformed: S aureus, C perfringens, B cereus Formed
More informationRapid Response Teams. January 17, Safe Table Webinar
Rapid Response Teams January 17, 2017 Safe Table Webinar Christin Gordanier, MSN, RN, Inpatient Nursing Director at Virginia Mason Medical Center in Seattle, Washington. Alice Ferguson, BSN, RN, Project
More informationGastrointestinal Hemorrhage
Gastrointestinal Hemorrhage Quality Measures Length of Stay RCC Costs per Case Mortality Rate Eligible Readmission Within 30 Days. Critical Event(s) Evaluation Phase/Acute Phase Baseline pain assessment
More informationDiagnosis: Allergies:
Patient Name: Diagnosis: Allergies: ICU Sepsis Version 5 1/11/17 This order set must be used with an admission order set if patient not already admitted. Nursing Orders Verify that cultures have been obtained
More informationAntimicrobial Stewardship and Urinary Tract Infections
Antimicrobial Stewardship and Urinary Tract Infections Samantha Loutzeheiser, PharmD, BCPS Andrea Pallotta, PharmD, BCPS (AQ-ID), AAHIVP Cleveland Clinic Medina Hospital Cleveland Clinic Main Campus Objectives
More informationHand-Carried Ultrasound Performed by a Hospitalist to Assist with Clinical Decisions in Medicine Inpatients: a Case Series
Hand-Carried Ultrasound Performed by a Hospitalist to Assist with Clinical Decisions in Medicine Inpatients: a Case Series Stefan Tchernodrinski, MD Cook County Hospital Chicago, Illinois Introduction
More informationVentilator Associated
Ventilator Associated Pneumonia: Key and Controversial Issues Christopher P. Michetti, MD, FACS Inova Fairfax Hospital, Falls Church, VA Forrest Dell Moore, MD, FACS Banner Healthcare System, Phoenix,
More informationEffect of Ortho-Geriatric Co-Management on Hip Fractures
Effect of Ortho-Geriatric Co-Management on Hip Fractures Kenji Shigemoto Takeshi Sawaguchi Daigo Sakagoshi Kenichi Goshima Yu Hatsuchi Dept. Orthop. Surg. Toyama Municipal Hospital, Toyama, Japan Purpose
More information9 Diabetes care. Back to contents
Back to contents Diabetes is a major risk factor for the development of peripheral vascular disease and 349/628 (55.6%) of the patients in this study had diabetes. Hospital inpatients with diabetes are
More informationHow did I decide on the topics?
Disclosures None How did I decide on the topics? Important papers within 1 year vs topics of importance or innovation/aha moments Sepsis Atrial Fibrillation Pneumonia Procalcitonin Objectives By the end
More informationCOPD exacerbation. Dr. med. Frank Rassouli
Definition according to GOLD report: - «An acute event - characterized by a worsening of the patients respiratory symptoms - that is beyond normal day-to-day variations - and leads to a change in medication»
More informationTroponin = 35. Objectives. Low Risk Chest Pain. Does this patient have ACS? Does this patient have ACS? Objectives
Objectives Low Risk Chest Pain Jeffrey Tabas, MD Professor of Emergency Medicine Office of CME UCSF School of Medicine Improve speed and accuracy in assessing patients with possible ACS! Avoid pitfalls
More informationCLINICAL DECISION SUPPORT FOR ME/ADE PREVENTION
CLINICAL DECISION SUPPORT FOR ME/ADE PREVENTION Sandra Kane-Gill, PharmD, MSc, FCCP, FCCM Associate Professor of Pharmacy, Critical Care Medicine and the Clinical Translational Science Institute, University
More informationUPDATE IN HOSPITAL MEDICINE
UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some
More informationLoyola s C diff Journey
Loyola s C diff Journey Kevin Smith, MD Associate Chief Medical Officer, Quality & Safety Aziz Ansari, DO Associate Chief Medical Officer, Clinical Optimization/Revenue Integrity Background Loyola Medicine
More informationUsefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
More informationFIS 2013, Birmingham
Fidaxomicin: CDDFT Case Studies Dr Deepa Nayar County Durham and Darlington Foundation Trust FIS 2013, Birmingham This meeting has been initiated and funded by Astellas Pharma Ltd. County Durham and Darlington
More informationThe Clinical Management of Hospital Acquired Pneumonia. NHS Ayrshire & Arran
The Clinical Management of Hospital Acquired Pneumonia Dr R G Masterton NHS Ayrshire & Arran What s new in HAP/VAP? Care bundles MRSA VAP Improving outcomes with current antimicrobial New antimicrobials
More informationTailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018
Tailored Volume Resuscitation in the Critically Ill is Achievable Heath E Latham, MD Associate Professor Fellowship Program Director Pulmonary and Critical Care Objectives Describe the goal of resuscitation
More informationSEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.
SEPSIS: IT ALL BEGINS WITH INFECTION Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft. Worth 1 2 3 OBJECTIVES Review the new Sepsis 3 definitions of sepsis
More informationRyan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center
Ryan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center The opinions expressed herein are solely those of the author and do not represent the official views of the Department of Defense
More informationPEDIATRIC LIFEGIFT BRAIN DEATH PLAN
PHYSICIAN S Diagnosis Weight Allergies Admit/Discharge/Transfer THIS PLAN IS TO BE ED ONLY ON THE LIFEGIFT ENCOUNTER, WITH DR LIFEGIFT AS THE ATTENDING. Patient Status Pt Status: Inpatient (Inpatient only
More informationThings your mother never told you about antibiotics, UTI s, and Pneumonia. Rob Kaplan, MD July 12 and 14, 2017
Things your mother never told you about antibiotics, UTI s, and Pneumonia Rob Kaplan, MD July 12 and 14, 2017 Objectives After this talk participants will: Be able to articulate some of the principles
More informationQuality Outcomes and Financial Benefits of Nutrition Intervention. Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition
Quality Outcomes and Financial Benefits of Nutrition Intervention Tracy R. Smith, PhD, RD, LD Senior Clinical Manager, Abbott Nutrition January 28, 2016 SHIFTING MARKET DYNAMICS PROVIDE AN OPPORTUNITY
More informationArchCare ASB:Proposed Guidelines-DS-8/17/12 Pg 1 of 5 ArchCare Proposed Clinical Guidelines: Asymptomatic Bacteriuria
Pg 1 of 5 ArchCare Proposed Clinical Guidelines: Asymptomatic Bacteriuria Asymptomatic Bacteriuria (ASB) is defined as a positive urine culture obtained from a person without signs or symptoms referable
More informationFever in neonates (age 0 to 28 days)
Fever in neonates (age 0 to 28 days) INCLUSION CRITERIA Infant 28 days of life Temperature 38 C (100.4 F) by any route/parental report EXCLUSION CRITERIA Infants with RSV Febrile Infant 28 days old Ill
More information12/1/2017. Disclosures. Objectives. The Microbiome Defined
Can Critical Illness and the Microbiome Play Nice Together? SCOTT BOLESTA, PHARMD, BCPS, FCCM ASSOCIATE PROFESSOR OF PHARMACY PRACTICE, WILKES UNIVERSITY VISITING INVESTIGATOR, GEISINGER HEALTH SYSTEM
More informationProprietary Acute Care Indicators
Proprietary Acute Care Indicators Indicator 1a: Device-Associated Infections in the Intensive Care Unit Central Line-Associated Bloodstream Infections in the APICU, CCU, MICU, M/S ICU, & SICU Ventilator-Associated
More informationCase. Case. Management of Pulmonary Embolism in the ICU
Management of Pulmonary Embolism in the ICU Todd M Bull, M.D. Associate Professor of Medicine Division of Pulmonary Sciences and Critical Care Medicine Pulmonary Hypertension Center University of Colorado
More informationLINKS OF INTEREST DISCLOSURE
LINKS OF INTEREST DISCLOSURE Name of the speaker: Sarah L. Krein I have no link of interest. www.sf2h.net 7, 8 et 9 juin 2017 And what about getting rid of catheter-associated urinary tract infections?
More informationThe Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It
The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It Cassie Brady, MD Assistant Professor of Pediatrics Division of Endocrinology and Diabetes Monroe Carell Junior Children s Hospital
More information1. Introduction Algorithm: Infant with Fever 0-28 Days Algorithm: Infant with Fever Days...3
These guidelines are designed to assist clinicians and are not intended to supplant good clinical judgement or to establish a protocol for all patients with this condition. MANAGEMENT OF FEVER 38 C (100.4F)
More informationClinical Controversies in Perioperative Medicine
Update on Perioperative Medicine Clinical Controversies in Perioperative Medicine Hugo Quinny Cheng, MD Division of Hospital Medicine University of California, San Francisco Cardiac Medications & Perioperative
More informationNancy Hailpern, Director, Regulatory Affairs K Street, NW, Suite 1000 Washington, DC 20005
Summary of Infection Prevention Issues in the Centers for Medicare & Medicaid Services (CMS) FY 2014 Inpatient Prospective Payment System (IPPS) Final Rule Hospital Readmissions Reduction Program-Fiscal
More information